[go: up one dir, main page]

CA2463384A1 - Gel nasal hydratant et applicateur - Google Patents

Gel nasal hydratant et applicateur Download PDF

Info

Publication number
CA2463384A1
CA2463384A1 CA002463384A CA2463384A CA2463384A1 CA 2463384 A1 CA2463384 A1 CA 2463384A1 CA 002463384 A CA002463384 A CA 002463384A CA 2463384 A CA2463384 A CA 2463384A CA 2463384 A1 CA2463384 A1 CA 2463384A1
Authority
CA
Canada
Prior art keywords
gel
nasal
hydrating
centipoise
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002463384A
Other languages
English (en)
Inventor
Jeffrey J. Fisher
Gustav R. Fenton
Milton W. Anderson
Richard E. Reever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CNS Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2463384A1 publication Critical patent/CA2463384A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne un gel nasal hydratant exerçant un effet apaisant sur la muqueuse de la cavité nasale. Ce gel, qui reste pendant un laps de temps prolongé dans la cavité nasale, atténue la sécheresse des tissus provoquées par un état pathologique ou par un milieu ambiant très sec. Le gel peut être appliqué sur les tissus intra-nasaux au moyen de l'embout d'un applicateur, ceci sensiblement sans contact avec les voies nasales.
CA002463384A 2001-10-12 2002-10-11 Gel nasal hydratant et applicateur Abandoned CA2463384A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32912301P 2001-10-12 2001-10-12
US32912201P 2001-10-12 2001-10-12
US60/329,122 2001-10-12
US60/329,123 2001-10-12
PCT/US2002/032606 WO2003030793A1 (fr) 2001-10-12 2002-10-11 Gel nasal hydratant et applicateur

Publications (1)

Publication Number Publication Date
CA2463384A1 true CA2463384A1 (fr) 2003-04-17

Family

ID=26986653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002463384A Abandoned CA2463384A1 (fr) 2001-10-12 2002-10-11 Gel nasal hydratant et applicateur

Country Status (5)

Country Link
EP (1) EP1450739A4 (fr)
JP (1) JP2005505587A (fr)
CA (1) CA2463384A1 (fr)
MX (1) MXPA04003359A (fr)
WO (1) WO2003030793A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US10111888B2 (en) 2011-05-13 2018-10-30 Acerus Biopharma Inc. Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US10668084B2 (en) 2011-05-13 2020-06-02 Acerus Biopharma Inc. Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11090312B2 (en) 2013-03-15 2021-08-17 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
EP2709588B1 (fr) * 2011-05-15 2021-08-25 Acerus Biopharma Inc. Gels nasaux de testostérone à libération prolongée, méthodes associées et systèmes applicateurs multi-doses pré-remplis destinés à une administration pernasale

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949262B1 (en) 2003-05-27 2005-09-27 Lousal Enterprises, Inc. Skin and mucosal treatment formulation
GB2431874A (en) * 2005-11-03 2007-05-09 Cst Medical Ltd Lubricant
NL2001342C2 (nl) * 2008-02-20 2009-08-24 Cornelis Boegem Balsem voor het afdekken van slijmvliezen tegen in de lucht aanwezige allergene stoffen, het gebruik van de balsem en een applicator voor de balsem.
CN106727277A (zh) * 2015-11-22 2017-05-31 中国人民解放军第三军医大学 一种含薄荷脑的鼻腔原位凝胶喷雾剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
US4724231A (en) * 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
US4781923A (en) * 1987-07-20 1988-11-01 Pellico Michael A Antiseptic gels
BR9007807A (pt) * 1989-10-31 1992-09-29 Columbia Lab Inc Composicao e metodo para umedecimento de tecido
GB9109775D0 (en) * 1991-05-04 1991-06-26 Procter & Gamble Cosmetic compositions
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
FR2694189B1 (fr) * 1992-07-30 1994-09-02 Sederma Sa Nouvelle méthode destinée à augmenter la viscosité des compositions cosmétiques.
GB9218834D0 (en) * 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
FR2744919B1 (fr) * 1996-02-21 1998-03-27 Stoa Sa Nouvelles compositions pour le traitement et la protection des mamelles des animaux de traite
JPH09253208A (ja) * 1996-03-21 1997-09-30 Unisia Jecs Corp 鼻腔用投薬器
EP0843556A1 (fr) * 1996-06-12 1998-05-27 Stoa S.A. Compositions pharmaceutiques a base de gels de type glyceryl poly(meth)acrylate
US6491940B1 (en) * 1999-01-27 2002-12-10 Bruce H. Levin Apparatus for administering composition for inhibiting cerebral neurovascular disorders and muscular headaches
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
DE19961307A1 (de) * 1999-12-18 2001-07-12 Krewel Meuselbach Gmbh Medizinprodukt zur Befeuchtung und Reinigung der Nasenschleimhaut
AU4594601A (en) * 2000-03-23 2001-10-03 Collaborative Technologies Inc Base compositions for preparing surfactant free topical compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US10111888B2 (en) 2011-05-13 2018-10-30 Acerus Biopharma Inc. Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US10668084B2 (en) 2011-05-13 2020-06-02 Acerus Biopharma Inc. Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
EP2709588B1 (fr) * 2011-05-15 2021-08-25 Acerus Biopharma Inc. Gels nasaux de testostérone à libération prolongée, méthodes associées et systèmes applicateurs multi-doses pré-remplis destinés à une administration pernasale
US11090312B2 (en) 2013-03-15 2021-08-17 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Also Published As

Publication number Publication date
JP2005505587A (ja) 2005-02-24
EP1450739A4 (fr) 2008-12-17
EP1450739A1 (fr) 2004-09-01
MXPA04003359A (es) 2004-11-29
WO2003030793A1 (fr) 2003-04-17

Similar Documents

Publication Publication Date Title
ES2291377T3 (es) Pelicula de espuma de celdas cerradas bioadhesiva de liberacion sostenida.
US4876092A (en) Sheet-shaped adhesive preparation applicable to oral cavity
CN110997054B (zh) 用于治疗身体表面病症的装置和方法
US11298316B2 (en) Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US20090053275A1 (en) Foam/spray producing compositions and dispencing system therefor
BR9710115B1 (pt) composiÇço aquosa farmacÊutica, e processo de preparaÇço de uma composiÇço aquosa farmacÊutica.
US5015474A (en) Composition for imparting moisture to a substrate
CN101219108A (zh) 相变制剂的药物传递
EP2896396A1 (fr) Formulation à base de plantes médicinales topiques pour le traitement des plaies topiques
JPH06128176A (ja) 薬効または化粧効果成分の浸透性増進方法
CN105636637A (zh) 用于治疗皮肤病症的组合物、方法和系统
US8668902B2 (en) Composition with activated carbon in oral treatment
US5137718A (en) Infection fighting composition for topical application
MX2008016486A (es) Composiciones herbales para el tratamiento de enfermedades de la cavidad oral.
ES3038299T3 (en) Dermal skin protectant and carrier
JP3064417B2 (ja) 放出制御性製剤及び方法
KR100814253B1 (ko) 상전이 유도 구취제거제
CA2463384A1 (fr) Gel nasal hydratant et applicateur
ES2452034T3 (es) Composición para el cuidado de prótesis dental
US20200069604A1 (en) Cannabinoid and anesthetic compositions and methods
US20060251704A1 (en) Methods and devices for efficacious treatment of aphthous ulcers
CA3176555A1 (fr) Menthol stabilise et autres compositions de composes volatils et procedes
Winfield Routes of administration and dosage forms
JPS6483024A (en) Cataplasm for cold
Kasture et al. Practical Pharmaceutics-I

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead